Login / Signup

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma.

Ryu SasakiKazuyoshi NagataMasanori FukushimaMasafumi HaraguchiSatoshi MiumaHisamitsu MiyaakiAkihiko SoyamaMasaaki HidakaSusumu EguchiMasaya ShigenoMio YamashimaShinobu YamamichiTatsuki IchikawaYuki KugiyamaHiroshi YatsuhashiKazuhiko Nakao
Published in: Cancers (2022)
The hepatobiliary phase of EOB-MRI was useful for predicting the therapeutic effect of atezolizumab plus bevacizumab therapy on unresectable HCC.
Keyphrases